1.
Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria
by Brooks, Ellen R
American journal of nephrology, 2016, Vol.43 (4), p.293-303

2.
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis
by Hoppe, B
Annals of the rheumatic diseases, 2009, Vol.68 (6), p.898-903

3.
Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9
by Mucha, Bettina
Pediatric research, 2006, Vol.59 (2), p.325-331

4.
Urinary oxalate excretion in urolithiasis and nephrocalcinosis
by Neuhaus, Thomas J
Archives of disease in childhood, 2000, Vol.82 (4), p.322-326

5.
Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death
by Henssge, C
International journal of legal medicine, 2000, Vol.113 (6), p.303-319

6.
Design and verification of the IBM System z10 I/O subsystem chips
by Schlipf, T.
IBM journal of research and development, 2009, Vol.53 (1), p.1-7:11

7.
Immune response in asthma: Down modulation by Schistosoma mansoni infection
by Araujo, M.I
Journal of allergy and clinical immunology, 2005, Vol.115 (2), p.S116-S116

8.
Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study
by Lagies, R
Pediatric nephrology (Berlin, West), 2019, Vol.34 (12), p.2591-2600

9.
Experiences with a compound method for estimating the time since death. II. Integration of non-temperature-based methods
by Henssge, C
International journal of legal medicine, 2000, Vol.113 (6), p.320-331

10.
A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria
by HOPPE, Bernd
Pediatric nephrology (Berlin, West), 2003, Vol.18 (10), p.986-991

11.
Hyperoxaluria in patients with primary distal renal tubular acidosis
by Mehler, K
Pediatric nephrology (Berlin, West), 2003, Vol.18 (7), p.722-723

12.
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
by Webb, Nicholas J. A
Pediatric nephrology (Berlin, West), 2017, Vol.32 (7), p.1221-1232

13.
Dent Disease with Mutations in OCRL1
by Hoopes, Richard R
American journal of human genetics, 2005, Vol.76 (2), p.260-267

14.
Functional verification of a frequency-programmable switch chip with asynchronous clock sections
by Hoppe, B
IBM journal of research and development, 2004, Vol.48 (3-4), p.461-474

15.
Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure
by HOPPE, B
Pediatric nephrology (Berlin, West), 1996, Vol.10 (4), p.488-492

16.
Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy
by Otto, Edgar A
Journal of Medical Genetics, 2011, Vol.48 (2), p.105-116

17.
Light microscopical investigations on structural changes of skeletal muscle as artifacts after postmortem stimulation
by Henssge, C
Forensic science international, 2002, Vol.125 (2), p.163-171

18.
Streptococcus pneumoniae-induced hemolytic uremic syndrome: report of a further case
by Gatter, N
Pediatric nephrology (Berlin, West), 2001, Vol.16 (10), p.840-840

19.
Management of primary hyperoxaluria: efficacy of oral citrate administration
by Leumann, E
Pediatric nephrology (Berlin, West), 1993, Vol.7 (2), p.207-211

20.
The Quickest Transshipment Problem
by Hoppe, Bruce
Mathematics of operations research, 2000, Vol.25 (1), p.36-62
